T

Trestle Biotherapeutics

4 employees

Trestle Biotherapeutics is a biotechnology company that introduces bioengineered kidneys for patients with kidney disease.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Life Science
Biopharma
Medical Device
Medical

Date founded

2020

Funding rounds raised

Total raised

$1M

from 4 investors over 4 rounds

T

Trestle Biotherapeutics raised $1M on June 12, 2023

Investors: KidneyX

T

Trestle Biotherapeutics raised undisclosed on March 22, 2021

Investors: Acequia Capital, Asymmetry Ventures and Y Combinator

FAQ